Citations (143)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Elisabeth Prevete, Valeria Catalani, Darshan Singh, Kim P. C. Kuypers, Eef L. Theunissen, Honor D. Townshend, Hani Banayoti, Johannes G. Ramaekers, Massimo Pasquini & Ornella Corazza. (2023) A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Joanna Hockenhull, David M Wood & Paul I. Dargan. (2023) Online availability of gabapentin and pregabalin and the impact of legal reclassification in the United Kingdom. Drugs: Education, Prevention and Policy 30:2, pages 222-226.
Read now
Read now
Jennifer Fleetwood, Judith Aldridge & Caroline Chatwin. (2020) Gendering research on online illegal drug markets. Addiction Research & Theory 28:6, pages 457-466.
Read now
Read now
Joanna Hockenhull, David M. Wood & Paul I. Dargan. (2020) The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription. Substance Use & Misuse 55:1, pages 56-65.
Read now
Read now
Surinporn Likhitsathian, Wichuda Jiraporncharoen, Apinun Aramrattana, Chaisiri Angkurawaranon, Manit Srisurapanont, Kanitta Thaikla, Sawitri Assanangkornchai, Manop Kanato, Usaneya Perngparn & Ratana Jarubenja. (2018) Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey. Journal of Substance Use 23:4, pages 384-389.
Read now
Read now
Kanokporn Pinyopornpanish, Wichuda Jiraporncharoen, Kanittha Thaikla, Kulyapa Yoonut & Chaisiri Angkurawaranon. (2018) Sedative and Analgesic Drugs Online: A Content Analysis of the Supply and Demand Information Available in Thailand. Substance Use & Misuse 53:4, pages 641-647.
Read now
Read now
Vendula Belackova, Martin Pazitny, Eva Drapalova, Magali Martinez, Daan van der Gouwe, Emma Begley, Michal Kidawa, Alexandra Tomkova & Daniela Kmetonynova. (2018) Assessing the impact of laws controlling the online availability of 25I-NBOMe, AH-7921, MDPV and MXE – outcomes of a semi-automated e-shop monitoring. Drugs: Education, Prevention and Policy 25:2, pages 109-117.
Read now
Read now
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston & Kevin Pangburn. (2017) Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015. Journal of Psychoactive Drugs 49:5, pages 436-445.
Read now
Read now
Filip M. Wiecko, William E. Thompson & Bryan P. Parham. (2017) A High By Any Other Name: Exploring the Motivations for Consumption of “Legal Highs”. Deviant Behavior 38:5, pages 549-560.
Read now
Read now
Evelyn Hearne & Marie Claire Van Hout. (2016) “Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction. Journal of Psychoactive Drugs 48:4, pages 233-242.
Read now
Read now
Anna Tarján, Mária Dudás, V. Anna Gyarmathy, Erzsébet Rusvai, Bálint Tresó & Ágnes Csohán. (2015) Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times. Substance Use & Misuse 50:7, pages 848-858.
Read now
Read now
Sindhu Siddiqi, Charlotte Verney, Paul Dargan & David M. Wood. (2015) Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology 53:1, pages 54-59.
Read now
Read now
M. Takematsu, R. S. Hoffman, L. S. Nelson, J. M. Schechter, J. H. Moran & S. W. Wiener. (2014) A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid. Clinical Toxicology 52:9, pages 973-975.
Read now
Read now
A.-E. Vermette-Marcotte, P. I. Dargan, J. R. H. Archer, S. Gosselin & D. M. Wood. (2014) An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clinical Toxicology 52:7, pages 678-681.
Read now
Read now
Christophe-Alain Bruneel, Christian Ben Lakhdar & Nicolas G. Vaillant. (2014) Are “Legal Highs” Users Satisfied? Evidence from Online Customer Comments. Substance Use & Misuse 49:4, pages 364-373.
Read now
Read now
Jodie Norman, Sharon Grace & Charlie Lloyd. (2014) Legal high groups on the internet – The creation of new organized deviant groups?. Drugs: Education, Prevention and Policy 21:1, pages 14-23.
Read now
Read now
David Michael Wood & Paul Ivor Dargan. (2014) Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance Alpha-methyltryptamine (AMT). Substance Use & Misuse 49:1-2, pages 7-12.
Read now
Read now
Marie Claire Van Hout & Rebekah Brennan. (2012) Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy 19:2, pages 156-162.
Read now
Read now
Marie
Claire Van Hout & Rebekah Brennan. (2011) ‘Heads Held High’: An Exploratory Study of Legal Highs in Pre-Legislation Ireland. Journal of Ethnicity in Substance Abuse 10:3, pages 256-272.
Read now
Read now
Faruk Asicioglu. (2010) New Psycho-Active Substances: The Legal Procedure Used in European Union Countries and Turkey. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 20:4, pages 334-339.
Read now
Read now
Articles from other publishers (123)
Rahni Hossain, Abida Sultana, Manit Nuinoon, Kunwadee Noonong, Jitbanjong Tangpong, Kazi Helal Hossain & Md Atiar Rahman. (2023) A Critical Review of the Neuropharmacological Effects of Kratom: An Insight from the Functional Array of Identified Natural Compounds. Molecules 28:21, pages 7372.
Crossref
Crossref
Silje Anderdal Bakken, Atte Oksanen & Jakob Demant. (2022) Capital in illegal online drug markets: How digital capital changes the cultural environment of drug dealing. Theoretical Criminology 27:3, pages 421-438.
Crossref
Crossref
A. N. Lodyagin, E. A. Rakhmanova & A. G. Miroshnichenko. (2023) Assessment of the severity of the condition of patients with acute substance poisoning using the PSS scale. HIV Infection and Immunosuppressive Disorders 15:1, pages 60-66.
Crossref
Crossref
Johan Söderberg. (2023) The psychedelic renaissance: a case of outlaw user innovation in the pharmaceutical industry. Prometheus 38:4.
Crossref
Crossref
Emily H. Garmon & Kandice Olson. (2022) Narrative Review of Kratom, an Emerging Psychoactive Substance With Perianesthetic Implications. Anesthesia & Analgesia 135:6, pages 1180-1188.
Crossref
Crossref
Islamudin Ahmad, Wisnu Cahyo Prabowo, Muhammad Arifuddin, Jaka Fadraersada, Niken Indriyanti, Herman Herman, Reza Yuridian Purwoko, Firzan Nainu, Anton Rahmadi, Swandari Paramita, Hadi Kuncoro, Nur Mita, Angga Cipta Narsa, Fajar Prasetya, Arsyik Ibrahim, Laode Rijai, Gemini Alam, Abdul Mun’im & Sukanya Dej-adisai. (2022) Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products. Life 12:2, pages 193.
Crossref
Crossref
Archana Kushwaha, Juhi Srivastava & Meenakshi Singh. (2022) EQCM sensor for targeting psychoactive drug via rationally designed molecularly imprinted polymeric nanoparticles (nanoMIPs). Materials Today: Proceedings 49, pages 3345-3356.
Crossref
Crossref
Arie P. Francis & Silas W. Smith. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
57
84
.
Matilda Hellman, Michael Egerer, Janne Stoneham, Sarah Forberger, Vilja Männistö-Inkinen, Doris Ochterbeck & Samantha RundleMatilda Hellman, Michael Egerer, Janne Stoneham, Sarah Forberger, Vilja Männistö-Inkinen, Doris Ochterbeck & Samantha Rundle. 2022. Addiction and the Brain. Addiction and the Brain
1
14
.
Robin van der Sanden, Chris Wilkins, Jose S. Romeo, Marta Rychert & Monica J. Barratt. (2021) Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey. International Journal of Drug Policy 98, pages 103430.
Crossref
Crossref
Karol Jędrejko, Jan Lazur & Bożena Muszyńska. (2021) Risk Associated with the Use of Selected Ingredients in Food Supplements. Chemistry & Biodiversity 18:2.
Crossref
Crossref
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Crossref
Camille Ramos, Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anna-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Martin Corkery & Fabrizio Schifano. (2020) Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances. Brain Sciences 10:3, pages 142.
Crossref
Crossref
Kamini Vijeepallam, Vijayapandi Pandy, DharmaniDevi Murugan & MuraliNaidu Kuppusamy. (2020)
Methanolic extract of
Mitragyna speciosa
Korth leaf exhibits place preference only at higher doses in mice
. Pharmacognosy Magazine 16:71, pages 449.
Crossref
Crossref
Heather M. Stieglitz & Steven W. Cotten. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory
373
377
.
Oskar Enghoff & Judith Aldridge. (2019) The value of unsolicited online data in drug policy research. International Journal of Drug Policy 73, pages 210-218.
Crossref
Crossref
Amy Peacock, Raimondo Bruno, Natasa Gisev, Louisa Degenhardt, Wayne Hall, Roumen Sedefov, Jason White, Kevin V Thomas, Michael Farrell & Paul Griffiths. (2019) New psychoactive substances: challenges for drug surveillance, control, and public health responses. The Lancet 394:10209, pages 1668-1684.
Crossref
Crossref
Bernd Werse, Annemieke Benschop, Gerrit Kamphausen, Marie-Claire van Hout, Susana Henriques, Joana Paula Silva, Katarzyna Dąbrowska, Łukasz Wieczorek, Michał Bujalski, Katalin Felvinczi & Dirk Korf. (2018) Sharing, Group-Buying, Social Supply, Offline and Online Dealers: how Users in a Sample from Six European Countries Procure New Psychoactive Substances (NPS). International Journal of Mental Health and Addiction 17:5, pages 1237-1251.
Crossref
Crossref
Hadil M. Elbardisy, Christopher W. Foster, Jack Marron, Ryan E. Mewis, Oliver B. Sutcliffe, Tarek S. Belal, Wael Talaat, Hoda G. Daabees & Craig E. Banks. (2019) Quick Test for Determination of N-Bombs (Phenethylamine Derivatives, NBOMe) Using High-Performance Liquid Chromatography: A Comparison between Photodiode Array and Amperometric Detection. ACS Omega 4:11, pages 14439-14450.
Crossref
Crossref
John M Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber & Amy Hendricks. (2019) Characteristics of deaths associated with kratom use. Journal of Psychopharmacology 33:9, pages 1102-1123.
Crossref
Crossref
Howbeer Muhamadali, Alexandra Watt, Yun Xu, Malama Chisanga, Abdu Subaihi, Carys Jones, David I. Ellis, Oliver B. Sutcliffe & Royston Goodacre. (2019) Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering. Frontiers in Chemistry 7.
Crossref
Crossref
Silje Anderdal Bakken & Jakob Demant. (2019) Narkotikamarkeder på nett. En begrepsutvikling av digital kapital. Norsk sosiologisk tidsskrift 3:3, pages 209-227.
Crossref
Crossref
Aleksi Hupli, Moritz Berning, Ahnjili Zhuparris & James Fadiman. (2019) Descriptive assemblage of psychedelic microdosing: Netnographic study of Youtube™ videos and on-going research projects. Performance Enhancement & Health 6:3-4, pages 129-138.
Crossref
Crossref
Noradliyanti Rusli, Azimah Amanah, Gurjeet Kaur, Mohd Ilham Adenan, Shaida Fariza Sulaiman, Habibah Abdul Wahab & Mei Lan Tan. (2019) The inhibitory effects of mitragynine on P-glycoprotein in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology 392:4, pages 481-496.
Crossref
Crossref
Vânia Meireles, Tiago Rosado, Mário Barroso, Sofia Soares, Joana Gonçalves, Ângelo Luís, Débora Caramelo, Ana Simão, Nicolás Fernández, Ana Duarte & Eugenia Gallardo. (2019) Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples. Medicines 6:1, pages 35.
Crossref
Crossref
Hadil M. Elbardisy, Alejandro García-Miranda Ferrari, Christopher W. Foster, Oliver B. Sutcliffe, Dale A. C. Brownson, Tarek S. Belal, Wael Talaat, Hoda G. Daabees & Craig E. Banks. (2019) Forensic Electrochemistry: The Electroanalytical Sensing of Mephedrone Metabolites. ACS Omega 4:1, pages 1947-1954.
Crossref
Crossref
Caroline Stokes Osborne, Amanda N. Overstreet, Don C. Rockey & Andrew D. Schreiner. (2019) Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. Journal of Investigative Medicine High Impact Case Reports 7, pages 232470961982616.
Crossref
Crossref
Michelle Williams, Jennifer Martin & Peter Galettis. (2019) A Validated Method for the Detection of Synthetic Cannabinoids in Oral Fluid. Journal of Analytical Toxicology 43:1, pages 10-17.
Crossref
Crossref
Leah Moyle, Andrew Childs, Ross Coomber & Monica J. Barratt. (2019) #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs. International Journal of Drug Policy 63, pages 101-110.
Crossref
Crossref
Mark Berry. (2018) Technology and organised crime in the smart city: an ethnographic study of the illicit drug trade. City, Territory and Architecture 5:1.
Crossref
Crossref
Kanittha Thaikla, Kanokporn Pinyopornpanish, Wichuda Jiraporncharoen & Chaisiri Angkurawaranon. (2018) Cannabis and Kratom online information in Thailand: Facebook trends 2015–2016. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Crossref
Rachelle Abouchedid, Thea Gilks, Paul I Dargan, John R. H Archer & David M Wood. (2018) Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UK. Journal of Medical Toxicology 14:2, pages 134-143.
Crossref
Crossref
Scott William Duxbury. (2015) Information creation on online drug forums: How drug use becomes moral on the margins of science. Current Sociology 66:3, pages 431-448.
Crossref
Crossref
Marie Claire Van Hout, Annemieke Benschop, Michal Bujalski, Katarzyna Dąbrowska, Zsolt Demetrovics, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Dirk Korf, Joana Paula Silva, Łukasz Wieczorek & Bernd Werse. (2017) Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries. International Journal of Mental Health and Addiction 16:2, pages 480-495.
Crossref
Crossref
Christopher N. Floyd, David M. Wood & Paul I. Dargan. (2017) Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability. European Journal of Clinical Pharmacology 74:3, pages 349-356.
Crossref
Crossref
Lisa SugiuraLisa Sugiura. 2018. Respectable Deviance and Purchasing Medicine Online. Respectable Deviance and Purchasing Medicine Online
21
65
.
Loren Tapp, Jessica G. Ramsey, Anita Wen & Roy Gerona. (2017) Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory — Nevada, 2014. MMWR. Morbidity and Mortality Weekly Report 66:47, pages 1291-1294.
Crossref
Crossref
Katherine N. Moore, Demetra Garvin, Brian F. Thomas & Megan Grabenauer. (2017) Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods. Journal of Forensic Sciences 62:5, pages 1151-1158.
Crossref
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Crossref
Marie Claire Van Hout & Evelyn Hearne. (2016) User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. International Journal of Mental Health and Addiction 15:3, pages 565-579.
Crossref
Crossref
Elle Wadsworth, Colin Drummond, Andreas Kimergård & Paolo Deluca. (2017) A market on both “sides” of the law: The use of the hidden web for the sale of new psychoactive substances. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2596.
Crossref
Crossref
John Martin Corkery, Laura Orsolini, Duccio Papanti & Fabrizio Schifano. (2017) From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS). Human Psychopharmacology: Clinical and Experimental 32:3, pages e2566.
Crossref
Crossref
Heather B. ClaytonRichard LowryCarmen AshleyAmy Wolkin & Althea M. Grant. (2017) Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. Pediatrics 139:4.
Crossref
Crossref
Anne Campbell, Nina O Neill & Kathryn Higgins. (2017) Health and Social Care workers’ perceptions of NPS use in Northern Ireland. International Journal of Drug Policy 40, pages 93-101.
Crossref
Crossref
Joan M. Striebel, Emily E. Nelson & Raj K. Kalapatapu. (2017) “Being with a Buddha”: A Case Report of Methoxetamine Use in a United States Veteran with PTSD. Case Reports in Psychiatry 2017, pages 1-4.
Crossref
Crossref
Moritz Berning & Anita Hardon. (2016) Educated Guesses and Other Ways to Address the Pharmacological Uncertainty of Designer Drugs. Contemporary Drug Problems 43:3, pages 277-292.
Crossref
Crossref
David R. Owen, David M. Wood, John R. H. Archer & Paul I. Dargan. (2016) Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review 35:5, pages 591-596.
Crossref
Crossref
Farah W. Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, Sharif M. Mansor, Visweswaran Navaratnam, Christian P. Müller & Zurina Hassan. (2016) Neurobiology of Kratom and its main alkaloid mitragynine. Brain Research Bulletin 126, pages 29-40.
Crossref
Crossref
Helge H. Müller, Johannes Kornhuber & Wolfgang Sperling. (2016) The behavioral profile of spice and synthetic cannabinoids in humans. Brain Research Bulletin 126, pages 3-7.
Crossref
Crossref
Wojciech Kolodziejczyk, Supratik Kar, Glake A. Hill & Jerzy Leszczynski. (2016) A comprehensive computational analysis of cathinone and its metabolites using quantum mechanical approaches and docking studies. Structural Chemistry 27:4, pages 1291-1302.
Crossref
Crossref
Kim Wolff. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
147
164
.
Ananya Mahapatra & Pawan Sharma. (2016) Internet snapshot survey: A novel methodology to monitor novel psychotropic substances and its need in Asia. Asian Journal of Psychiatry 21, pages 7-8.
Crossref
Crossref
Flaminia Pantano, Roberta Tittarelli, Giulio Mannocchi, Simona Zaami, Serafino Ricci, Raffaele Giorgetti, Daniela Terranova, Francesco Busardò & Enrico Marinelli. (2016) Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat. International Journal of Molecular Sciences 17:4, pages 580.
Crossref
Crossref
Vivekanand Sharma, John Holmes & Indra Sarkar. (2018) Identifying Complementary and Alternative Medicine Usage Information from Internet Resources. Methods of Information in Medicine 55:04, pages 322-332.
Crossref
Crossref
Nurul H. M. Yusoff, Farah W. Suhaimi, Raja K. Vadivelu, Zurina Hassan, Anne Rümler, Andrea Rotter, Davide Amato, Hans C. Dringenberg, Sharif M. Mansor, Visweswaran Navaratnam & Christian P. Müller. (2016) Abuse potential and adverse cognitive effects of mitragynine (kratom). Addiction Biology 21:1, pages 98-110.
Crossref
Crossref
Dessa Bergen-Cico & Kendra MacClurg. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
903
911
.
Fabio Del Vigna, Marco Avvenuti, Clara Bacciu, Paolo Deluca, Marinella Petrocchi, Andrea Marchetti & Maurizio Tesconi. 2016. Advances in Intelligent Data Analysis XV. Advances in Intelligent Data Analysis XV
86
97
.
E.H. Fletcher, S.M. Tasker, P. Easton & L. Denvir. (2015) Improving the help and support provided to people who take new psychoactive substances (‘legal highs’). Journal of Public Health, pages fdv191.
Crossref
Crossref
Johanna J. Nugteren-van Lonkhuyzen, Antoinette J.H.P. van Riel, Tibor M. Brunt & Laura Hondebrink. (2015) Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug and Alcohol Dependence 157, pages 18-27.
Crossref
Crossref
Tiggey May & Bina Bhardwa. 2015. The Handbook of Drugs and Society. The Handbook of Drugs and Society
416
441
.
James H. Ho, George P. Bailey, John R. H. Archer, Paul I. Dargan & David M. Wood. (2015) Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance. European Journal of Clinical Pharmacology 71:10, pages 1185-1196.
Crossref
Crossref
C. Lovett, D. M. Wood & P. I. Dargan. (2015) Pharmacology and toxicology of the synthetic cannabinoid receptor agonistsPharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes. Réanimation 24:5, pages 527-541.
Crossref
Crossref
James Glanville, Paul I. Dargan & David M. Wood. (2015) 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR, 4,4′-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity. Human Psychopharmacology: Clinical and Experimental 30:3, pages 193-198.
Crossref
Crossref
Benjamin R. Nordstrom, Sarah C. Akerman & Frances R. Levin. 2015. Psychiatry. Psychiatry
1458
1469
.
Hisham Nizar, Paul I. Dargan & David M. Wood. (2014) Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance 4-Methylaminorex and 4,4′-Dimethylaminorex. Journal of Medical Toxicology 11:1, pages 80-84.
Crossref
Crossref
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, Darshan Singh, Zsolt Demetrovics, Andres Roman-Urrestarazu, Francesco Saverio Bersani, Balasingam Vicknasingam, Giulia Piazzon, Jih-Heng Li, Wen-Jing Yu, Máté Kapitány-Fövény, Judit Farkas, Massimo Di Giannantonio & Ornella Corazza. (2015)
Following “the Roots” of Kratom (
Mitragyna speciosa
): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Brenda Curtis, Kelly Alanis-Hirsch, Övgü Kaynak, John Cacciola, Kathy Meyers & Anthony Thomas McLellan. (2015) Using Web searches to track interest in synthetic cannabinoids (aka ‘herbal incense’). Drug and Alcohol Review 34:1, pages 105-108.
Crossref
Crossref
Lisa Shostak & Ben Harper. 2015. Young People in Forensic Mental Health Settings. Young People in Forensic Mental Health Settings
253
285
.
Khaled Y. Zuway, Jamie P. Smith, Christopher W. Foster, Nikil Kapur, Craig E. Banks & Oliver B. Sutcliffe. (2015) Detection and quantification of new psychoactive substances (NPSs) within the evolved “legal high” product, NRG-2, using high performance liquid chromatography-amperometric detection (HPLC-AD). The Analyst 140:18, pages 6283-6294.
Crossref
Crossref
Loanda R. Cumba, Athanasios V. Kolliopoulos, Jamie P. Smith, Paul D. Thompson, Peter R. Evans, Oliver B. Sutcliffe, Devaney R. do Carmo & Craig E. Banks. (2015) Forensic electrochemistry: indirect electrochemical sensing of the components of the new psychoactive substance “Synthacaine”. The Analyst 140:16, pages 5536-5545.
Crossref
Crossref
Victor M.R. Zancajo, J. Brito, Marta P. Carrasco, M.R. Bronze, Rui Moreira & Alvaro Lopes. (2014) Analytical profiles of “legal highs” containing cathinones available in the area of Lisbon, Portugal. Forensic Science International 244, pages 102-110.
Crossref
Crossref
Chris Wilkins. (2014) A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand. Addiction 109:10, pages 1580-1586.
Crossref
Crossref
Andrey Zheluk, Casey Quinn & Peter Meylakhs. (2014) Internet Search and Krokodil in the Russian Federation: An Infoveillance Study. Journal of Medical Internet Research 16:9, pages e212.
Crossref
Crossref
Aileen O’Gorman, Eoghan Quigley, Frank Zobel & Kerri Moore. (2014) Peer, professional, and public: An analysis of the drugs policy advocacy community in Europe. International Journal of Drug Policy 25:5, pages 1001-1008.
Crossref
Crossref
Lucas R. Watterson & M. Foster Olive. (2014) Synthetic Cathinones and Their Rewarding and Reinforcing Effects in Rodents. Advances in Neuroscience 2014, pages 1-9.
Crossref
Crossref
Darshan Singh, Christian P. Müller & Balasingam K. Vicknasingam. (2014) Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139, pages 132-137.
Crossref
Crossref
Tracy L. Brewer & Margie Collins. (2014) A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids. Journal for Specialists in Pediatric Nursing 19:2, pages 119-126.
Crossref
Crossref
Nicolas Hohmann, Gerd Mikus & David Czock. (2014) Effects and Risks Associated with Novel Psychoactive Substances. Deutsches Ärzteblatt international.
Crossref
Crossref
Jamie P. Smith, Jonathan P. Metters, Craig Irving, Oliver B. Sutcliffe & Craig E. Banks. (2014) Forensic electrochemistry: the electroanalytical sensing of synthetic cathinone-derivatives and their accompanying adulterants in “legal high” products. The Analyst 139:2, pages 389-400.
Crossref
Crossref
Joel Schlatter. 2014.
291
311
.
Heesun Chung, Hyeyoung Choi, Sewoong Heo, Eunmi Kim & Jaesin Lee. (2013) Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013. Forensic Toxicology 32:1, pages 82-88.
Crossref
Crossref
Amy K. Goodwin, K. Michael Gibson & Elise M. Weerts. (2013) Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): Time course and severity of withdrawal in baboons. Drug and Alcohol Dependence 132:3, pages 427-433.
Crossref
Crossref
Robin M. Murray, Alessandra Paparelli, Paul D. Morrison, Arianna Marconi & Marta Di Forti. (2013) What can we learn about schizophrenia from studying the human model, drug-induced psychosis?. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162:7, pages 661-670.
Crossref
Crossref
A Bakarr Kanu, Simon D. BrandtMike D. Williams, Nancy Zhang & Herbert H. Hill. (2013) Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry. Analytical Chemistry 85:18, pages 8535-8542.
Crossref
Crossref
Lucas R. Watterson, Elizabeth Watterson & Michael Foster Olive. (2013) Abuse liability of novel ‘legal high’ designer stimulants. Behavioural Pharmacology 24:5 and 6, pages 341-355.
Crossref
Crossref
Jolanta B. Zawilska & Jakub Wojcieszak. (2013) Designer cathinones—An emerging class of novel recreational drugs. Forensic Science International 231:1-3, pages 42-53.
Crossref
Crossref
Janie Sheridan, Christine Yang Dong, Rachael Butler & Joanne Barnes. (2013) The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: Results of a longitudinal, web-based study. International Journal of Drug Policy 24:5, pages 412-422.
Crossref
Crossref
Pierluigi Simonato, Ornella Corazza, Paolo Santonastaso, John Corkery, Paolo Deluca, Zoe Davey, Ursula Blaszko & Fabrizio Schifano. (2013) Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Human Psychopharmacology: Clinical and Experimental 28:4, pages 324-331.
Crossref
Crossref
Warunya Arunotayanun, Jeffrey W. Dalley, Xi-Ping Huang, Vincent Setola, Ric Treble, Leslie Iversen, Bryan L. Roth & Simon Gibbons. (2013) An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: Emerging ‘Novel Psychoactive Drugs’. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3411-3415.
Crossref
Crossref
Hyeyoung Choi, Sewoong Heo, Sanggil Choe, Wonkyung Yang, Yuran Park, Eunmi Kim, Heesun Chung & Jaesin Lee. (2012) Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Analytical and Bioanalytical Chemistry 405:12, pages 3937-3944.
Crossref
Crossref
Peter N. Carbone, David L. Carbone, Shaun D. Carstairs & Scott A. Luzi. (2013) Sudden Cardiac Death Associated With Methylone Use. American Journal of Forensic Medicine & Pathology 34:1, pages 26-28.
Crossref
Crossref
John Lally, Emam-El Higaya, Zafar Nisar, Emma Bainbridge & Brian Hallahan. (2018) Prevalence study of head shop drug usage in mental health services. The Psychiatrist 37:2, pages 44-48.
Crossref
Crossref
Zurina Hassan, Mustapha Muzaimi, Visweswaran Navaratnam, Nurul H.M. Yusoff, Farah W. Suhaimi, Rajakumar Vadivelu, Balasingam K. Vicknasingam, Davide Amato, Stephan von Hörsten, Nurul I.W. Ismail, Nanthini Jayabalan, Ammar I. Hazim, Sharif M. Mansor & Christian P. Müller. (2013) From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37:2, pages 138-151.
Crossref
Crossref
Iván Fornís Espinosa, Claudio Vidal Giné, Fernando Caudevilla Gálligo & Mireia Ventura Vilamala. (2013) Nuevas drogas de síntesis: legal highs en España (2010-2012). Medicina Clínica 140:4, pages 189-190.
Crossref
Crossref
Amy K. Goodwin, Barbara J. Kaminski & Elise M. Weerts. (2012) Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology 225:3, pages 637-646.
Crossref
Crossref
Samuel Mabbott, Elon Correa, David P. Cowcher, J. William Allwood & Royston Goodacre. (2012) Optimization of Parameters for the Quantitative Surface-Enhanced Raman Scattering Detection of Mephedrone Using a Fractional Factorial Design and a Portable Raman Spectrometer. Analytical Chemistry 85:2, pages 923-931.
Crossref
Crossref
Savithiri Ratnapalan. (2013) Legal substances and their abuse: Legal highs. Journal of Paramedic Practice 5:1, pages 40-51.
Crossref
Crossref
Wan-Yu Chiu, Gwo-Hshiung Tzeng & Han-Lin Li. (2013) A new hybrid MCDM model combining DANP with VIKOR to improve e-store business. Knowledge-Based Systems 37, pages 48-61.
Crossref
Crossref
Osama I.G. Khreit, M. Helen Grant, Tong Zhang, Catherine Henderson, David G. Watson & Oliver B. Sutcliffe. (2013) Elucidation of the Phase I and Phase II metabolic pathways of (±)-4′-methylmethcathinone (4-MMC) and (±)-4′-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC–MS and LC–MS2. Journal of Pharmaceutical and Biomedical Analysis 72, pages 177-185.
Crossref
Crossref
Chris Wilkins & Paul Sweetsur. (2013) The impact of the prohibition of benzylpiperazine (BZP) ‘legal highs’ on the prevalence of BZP, new legal highs and other drug use in New Zealand. Drug and Alcohol Dependence 127:1-3, pages 72-80.
Crossref
Crossref
Silas W. Smith & Fiona M. Garlich. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
55
77
.
Roumen Sedefov, Ana Gallegos, Jane Mounteney & Padraigin Kenny. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
29
54
.
Jaesin Lee, Sanggil Choe, Hyeyoung Choi, Sewoong Heo, Eunmi Kim, Hyunju Kim, Eunjung Bang & Heesun Chung. (2012) Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug?. Forensic Toxicology 31:1, pages 54-58.
Crossref
Crossref
Paolo Deluca, Zoe Davey, Ornella Corazza, Lucia Di Furia, Magi Farre, Liv Holmefjord Flesland, Miia Mannonen, Aino Majava, Teuvo Peltoniemi, Manuela Pasinetti, Cinzia Pezzolesi, Norbert Scherbaum, Holger Siemann, Arvid Skutle, Marta Torrens, Peer van der Kreeft, Erik Iversen & Fabrizio Schifano. (2012) Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 221-226.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 227-233.
Crossref
Crossref
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran & Liana Fattore. (2012) Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 234-243.
Crossref
Crossref
Rebekah Brennan & Marie Claire Van Hout. (2012) Miaow miaow: a review of the new psychoactive drug mephedrone. Drugs and Alcohol Today 12:4, pages 241-253.
Crossref
Crossref
Niamh NicDaéidWolfram Meier-AugensteinHelen F. KempOliver B. Sutcliffe. (2012) Using Isotopic Fractionation to Link Precursor to Product in the Synthesis of (±)-Mephedrone: A New Tool for Combating “Legal High” Drugs. Analytical Chemistry 84:20, pages 8691-8696.
Crossref
Crossref
Erik W. Gunderson, Heather M. Haughey, Nassima Ait‐Daoud, Amruta S. Joshi & Carl L. Hart. (2012) “Spice” and “K2” Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans. The American Journal on Addictions 21:4, pages 320-326.
Crossref
Crossref
Marie Claire Van Hout & Tim Bingham. (2012) “A Costly Turn On”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy 23:3, pages 188-197.
Crossref
Crossref
Susannah Davies, Terry Lee, John Ramsey, Paul I. Dargan & David M. Wood. (2011) Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances). European Journal of Clinical Pharmacology 68:4, pages 435-439.
Crossref
Crossref
Osama I.G. Khreit, Craig Irving, Elke Schmidt, John A. Parkinson, Niamh Nic Daeid & Oliver B. Sutcliffe. (2012) Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved “legal high” NRG-2. Journal of Pharmaceutical and Biomedical Analysis 61, pages 122-135.
Crossref
Crossref
Dariusz Zuba. (2012) Identification of cathinones and other active components of ‘legal highs’ by mass spectrometric methods. TrAC Trends in Analytical Chemistry 32, pages 15-30.
Crossref
Crossref
Karen McelrathMarie Claire Van Hout. (2011) A Preference for Mephedrone: Drug Markets, Drugs of Choice, and the Emerging “Legal High” Scene. Journal of Drug Issues 41:4, pages 487-507.
Crossref
Crossref
Eman Y. Santali, Anna-Karina Cadogan, Niamh Nic Daeid, Kathleen A. Savage & Oliver B. Sutcliffe. (2011) Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4′-methylmethcathinone (mephedrone): A new “legal high”. Journal of Pharmaceutical and Biomedical Analysis 56:2, pages 246-255.
Crossref
Crossref
Laurent Karila & Michel Reynaud. (2010) GHB and synthetic cathinones: clinical effects and potential consequences. Drug Testing and Analysis 3:9, pages 552-559.
Crossref
Crossref
Paul I. Dargan, Roumen Sedefov, Ana Gallegos & David M. Wood. (2011) The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Testing and Analysis 3:7-8, pages 454-463.
Crossref
Crossref
Marie Claire Van Hout & Rebekah Brennan. (2011) “Bump and grind”: an exploratory study of Mephedrone users' perceptions of sexuality and sexual risk. Drugs and Alcohol Today 11:2, pages 93-103.
Crossref
Crossref
Chimdi Uhoegbu, Eric Kolshus, Izu Nwachukwu, Allys Guerandel & Caroline Maher. (2014) Two psychiatric presentations linked with ‘head shop’ products. Irish Journal of Psychological Medicine 28:1, pages S8-S10.
Crossref
Crossref
Martin M. Schmidt, Akhilesh Sharma, Fabrizio Schifano & Charlotte Feinmann. (2011) “Legal highs” on the net—Evaluation of UK-based Websites, products and product information. Forensic Science International 206:1-3, pages 92-97.
Crossref
Crossref
Karen McElrath & Christina O’Neill. (2011) Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy 22:2, pages 120-127.
Crossref
Crossref
G. Hussein RassoolG. Hussein Rassool. 2011. Understanding Addiction Behaviours. Understanding Addiction Behaviours
137
142
.
Simon Gibbons & Mire Zloh. (2010) An analysis of the ‘legal high’ mephedrone. Bioorganic & Medicinal Chemistry Letters 20:14, pages 4135-4139.
Crossref
Crossref